4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Exploring the function of factor XIII free B subunit: Interactions with complement factors and a novel approach to identify potential binding partners

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          The factor XIII (FXIII)‐B subunit has a critical function as a carrier protein to stabilize FXIII‐A in plasma and supply it to its main substrate, fibrinogen. However, the function of the excess free FXIII‐B circulating in plasma is still elusive.

          Objectives

          In the present study, we explored potential interactions of free FXIII‐B with complement factors and searched for novel binding partners.

          Methods

          We tested for cofactor activity in the degradation of complement C3b and C4b and used ELISA‐ and surface plasmon resonance–based binding assays to investigate interactions between FXIII‐B and complement components. We performed immunoprecipitation and mass spectrometry analysis to identify potential binding partners of free FXIII‐B in freshly drawn plasma samples.

          Results

          FXIII‐B did not exhibit cofactor activity in the degradation of C3b and C4b similar to factor H and C4b‐binding protein, nor did it bind to complement factors to a relevant extent. Identification of proteins potentially binding to free FXIII‐B revealed high interindividual variation. We confirmed α 2‐macroglobulin (α2MG) as a candidate, although direct interactions or functional effects remain to be validated.

          Conclusions

          Our study reveals that free FXIII‐B has no direct role in regulating the complement system, despite a structural similarity to major complement regulators. Further studies are needed to validate α2MG as a binding partner and explore potential functional consequences of this binding.

          Related collections

          Most cited references27

          • Record: found
          • Abstract: found
          • Article: not found

          Complement: a key system for immune surveillance and homeostasis.

          Nearly a century after the significance of the human complement system was recognized, we have come to realize that its functions extend far beyond the elimination of microbes. Complement acts as a rapid and efficient immune surveillance system that has distinct effects on healthy and altered host cells and foreign intruders. By eliminating cellular debris and infectious microbes, orchestrating immune responses and sending 'danger' signals, complement contributes substantially to homeostasis, but it can also take action against healthy cells if not properly controlled. This review describes our updated view of the function, structure and dynamics of the complement network, highlights its interconnection with immunity at large and with other endogenous pathways, and illustrates its multiple roles in homeostasis and disease.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Complement control protein factor H: the good, the bad, and the inadequate.

            The complement system is an essential component of the innate immune system that participates in elimination of pathogens and altered host cells and comprises an essential link between the innate and adaptive immune system. Soluble and membrane-bound complement regulators protect cells and tissues from unintended complement-mediated injury. Complement factor H is a soluble complement regulator essential for controlling the alternative pathway in blood and on cell surfaces. Normal recognition of self-cell markers (i.e. polyanions) and C3b/C3d fragments is necessary for factor H function. Inadequate recognition of host cell surfaces by factor H due to mutations and polymorphisms have been associated with complement-mediated tissue damage and disease. On the other hand, unwanted recognition of pathogens and altered self-cells (i.e. cancer) by factor H is used as an immune evasion strategy. This review will focus on the current knowledge related to these versatile recognition properties of factor H. Copyright 2010 Elsevier Ltd. All rights reserved.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              α-2-Macroglobulin: a physiological guardian.

              Alpha macroglobulins are large glycoproteins which are present in the body fluids of both invertebrates and vertebrates. Alpha-2-macroglobulin (α2 M), a key member of alpha macroglobulin superfamily, is a high-molecular weight homotetrameric glycoprotein. α2 M has many diversified and complex functions, but it is primarily known by its ability to inhibit a broad spectrum of proteases without the direct blockage of the protease active site. α2 M is also known to be involved in the regulation, transport, and a host of other functions. For example, apart from inhibiting proteinases, it regulates binding of transferrin to its surface receptor, binds defensin and myelin basic protein, etc., binds several important cytokines, including basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), nerve growth factor (NGF), interleukin-1β (IL-1β), and interleukin-6 (IL-6), and modify their biological activity. α2 M also binds a number of hormones and regulates their activity. α2 M is said to protect the body against various infections, and hence, can be used as a biomarker for the diagnosis and prognosis of a number of diseases. However, this multipurpose antiproteinse is not "fail safe" and could be damaged by reactive species generated endogenously or exogenously, leading to various pathophysiological conditions. Copyright © 2012 Wiley Periodicals, Inc.
                Bookmark

                Author and article information

                Contributors
                verena.schroeder@dbmr.unibe.ch
                Journal
                Res Pract Thromb Haemost
                Res Pract Thromb Haemost
                10.1002/(ISSN)2475-0379
                RTH2
                Research and Practice in Thrombosis and Haemostasis
                John Wiley and Sons Inc. (Hoboken )
                2475-0379
                21 July 2022
                July 2022
                : 6
                : 5 ( doiID: 10.1002/rth2.v6.5 )
                : e12766
                Affiliations
                [ 1 ] Experimental Haemostasis Group, Department for BioMedical Research DBMR University of Bern Bern Switzerland
                [ 2 ] Molecular Pharmacy Group, Department of Pharmaceutical Sciences University of Basel Basel Switzerland
                Author notes
                [*] [* ] Correspondence

                Verena Schroeder, Experimental Haemostasis Group, Department for BioMedical Research, University of Bern, Murtenstrasse 40, 3008 Bern, Switzerland.

                Email: verena.schroeder@ 123456dbmr.unibe.ch

                Author information
                https://orcid.org/0000-0001-6508-3271
                Article
                RTH212766 RPTH-2022-00036.R2
                10.1002/rth2.12766
                9301527
                35873217
                0ca02714-eab1-41c3-a65c-288c2340934e
                © 2022 The Authors. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH).

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 30 May 2022
                : 20 January 2022
                : 16 June 2022
                Page count
                Figures: 6, Tables: 1, Pages: 12, Words: 5938
                Funding
                Funded by: OPO Foundation
                Funded by: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
                Award ID: 310030_169220
                Award ID: 31003A_176104
                Categories
                Original Article
                Original Articles
                Custom metadata
                2.0
                July 2022
                Converter:WILEY_ML3GV2_TO_JATSPMC version:6.1.7 mode:remove_FC converted:21.07.2022

                α 2‐macroglobulin,coagulation factor xiii,complement system,factor xiii b‐subunit

                Comments

                Comment on this article